ACUTA CAPITAL PARTNERS, LLC

13D and 13G Filings

Issuer % of Class Filed
Schedule 13D · 1 security · may seek to influence control
Whitehawk Therapeutics, Inc. 13D/A
WHWK · 00032Q104
9.0% 5/18/2026
Event 5/14/2026

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.